Background illustration for clinical trials search

Brain Cancer Clinical Trials

Browse 315 brain cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

for
Recurrent Ependymoma, Recurrent Medulloblastoma,
Location: Houston TX
Sponsor: Jeffrey Treiber

Sex: All

Age: 1 - 70+

Code: NCT06466798

Phase1, Recruiting

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

for
Cerebral Palsy, Dyskinetic, Secondary Dystonia
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 8 - 22

Code: NCT06036199

Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for
Wilms Tumor, Rhabdoid Tumor,
Location: Boston MA, Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT05985161

Phase2, Recruiting

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

for
Diffuse Intrinsic Pontine Glioma, High Grade Glioma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 1 - 25

Code: NCT04099797

Phase1, Recruiting

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

for
CNS Lymphoma, Primary Central Nervous System Lymphoma,
Location: San Francisco CA
Sponsor: James Rubenstein

Sex: All

Age: 18+

Code: NCT05351593

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

for
Melanoma (Skin)
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05704647

Phase2, Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

for
Relapsed Hematologic Malignancy,
Location: Boston MA, New York NY, Durham NC, Buffalo NY,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT03328078

Phase1, Phase2, Recruiting

Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

for
Pediatric Disorder, Genetic Predisposition, Dystonia, Secondary,
Location: Kansas City MO
Sponsor: Children's Mercy Hospital Kansas City

Sex: All

Age: 5 - 17

Code: NCT06554288

Phase1, Recruiting

Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy

for
Lymphoma Receiving CAR-T Therapy
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04107285

Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

for
Primary CNS Lymphoma
Location: San Francisco CA
Sponsor: James Rubenstein

Sex: All

Age: 18+

Code: NCT04656431

Phase1, Recruiting

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

for
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04479696

Recruiting

Feasibility of FMISO in Brain Tumors

for
IDH Wild Type Glioblastoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT03649880

Phase2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New York NY, Livingston NJ, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

for
Brain Cancer, Glioma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00870129

Recruiting

Wearable Devices and Biomarkers Project (Healthiomics)

for
Brain Cancer, Neurological Disorder, Neurological Cancer
Location: San Diego CA
Sponsor: CureScience

Sex: All

Age: 18+

Code: NCT05106725

Recruiting

Digital Art Therapy for Young Cancer Survivors

for
Cancer, Pediatric Cancer, Pediatric Malignancies,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 25

Code: NCT06789666

Recruiting

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

for
Malignant Brain Neoplasm, Malignant Glioma
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT03510208

Phase1, Phase2, Recruiting

Florida Center for Brain Tumor Research

for
Brain Tumors
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 0+

Code: NCT00811148

Recruiting

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

for
Brain Tumor Adult
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70

Code: NCT03067467

Recruiting